Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance
14.07.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced the appointment of three seasoned leaders to the ... Seite 1